Rimonabant

Chemical formula: C₂₂H₂₁Cl₃N₄O  Molecular mass: 463.787 g/mol  PubChem compound: 104850

Therapeutic indications

Rimonabant is indicated for:

Obese associated type 2 diabetes

Population group: only adults (18 years old or older)

As an adjunct to diet and exercise for the treatment of obese patients (BMI ≥30 kg/m²), or overweight patients (BMI >27 kg/m²) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Rimonabant is contraindicated in the following cases:

Lactation

Lactation

Major depressive illness, antidepressives

at least one of
Major depressive disorder
Antidepressants

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2009: ACOMPLIA Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈